The National Institute for Communicable Diseases (NICD) in South Africa confirmed on 16 February 2022 that multiple outbreaks of typhoid fever occurred in the Western Cape and North West.
According to WHO, an estimated 11–21 million people get sick from typhoid and between 128 000 and 161 000 people die from it every year. Communities lacking access to safe drinking water and adequate sanitation, and vulnerable groups including children are at highest risk.
Reszon Typhoid Rapid lgM and Reszon Typhoid Rapid lgG/lgM (Combo) Tests are immunochromatographic assays designed for qualitative detection of Typhoid fever. Reszon Typhoid Rapid IgM is designed to detect specific IgM antibodies IgM antibodies against a specific Salmonella typhi antigen in human serum, plasma or whole blood specimen while Reszon Typhoid Rapid lgG/lgM (Combo) is intended for qualitative detection and differentiation of specific IgM and IgG antibodies against specific Salmonella typhi OMP antigen in human serum or plasma specimen.
Both test kits are available in the packing size of 25 tests per kit and intended to be used by medical professional for early diagnosis of Typhoid fever.
Learn more:
TYPHOID RAPID IgM TEST
TYPHOID RAPID IgG/IgM (COMBO) TEST
Reference:
Estelle Ellis (2022) Outbreaks of typhoid fever confirmed in Western Cape and North West. Daily Maverick. Accessed on 5 Dec 2022.
